Page 30 - Read Online

experience 1970-1986. Radiother Oncol 1991;21:183-92. squamous cell carcinoma of the oral cavity. Arch Otolaryngol Head Neck Surg
46. Fujita M, Hirokawa Y, Kashiwado K, Akagi Y, Kashimoto K, Kiriu H, 2010;136:225-8.
Matsuura K, Ito K. Interstitial brachytherapy for stage I and II squamous 64. Leemans CR, Tiwari T, Nauta JJ, van der Waal L, Snow GB. Regional
cell carcinoma of the oral tongue: factors influencing local control and soft Lymph node involvement and its signficance in the development of distan
tissue complications. Int J Radiat Oncol Biol Phys 1999;44:767-75. metastases in head and neck carcinoma. Cancer 1993;71:452-6.
47. Ihara N, Shibuya H, Yoshimura R, Oota S, Miura M, Watanabe H. Interstitial 65. Cooper JS, Pajak TF, Forastiere A, Jacobs J, Fu KK, Ang KK, Laramore
brachytherapy and neck dissection for Stage III squamous cell carcinoma GE, Al-Sarraf M. Precisely defining high-risk operable head and neck
of the mobile tongue. Acta Oncol 2005;44:709-16. tumors based on RTOG #83-03 and #88-24: Targets for postoperative
48. Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot radiochemotherapy? Head Neck 1998;20:588-94.
JC, Le Maître A, Pajak TF, Poulsen MG, O’Sullivan B, Dobrowsky W, Hliniak 66. Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans
A, Skladowski K, Hay JH, Pinto LH, Fallai C, Fu KK, Sylvester R, Pignon JP; CR. Risk group definition by recursive partitioning analysis of patients
Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) with squamous cell head and neck carcinoma treated with surgery and
collaborative group. Hyperfractionated or accelerated radiotherapy in postoperative radiotherapy. Cancer 2005;104:1408-17.
head and neck cancer: a meta-analysis. Lancet 2006;368:843-54. 67. Jonkman A, Kaanders JH, Terhaard CH, Hoebers FJ, van den Ende PL, Wijers
49. Glenny AM, Furness S, Worthington HV, Conway DI, Oliver R, Clarkson OB, Verhoef LC, de Jong MA, Leemans CR, Langendijk JA. Multicenter
JE, Macluskey M, Pavitt S, Chan KK, Brocklehurst P; CSROC Expert Panel. validation of recursive partitioning analysis classification for patients
Interventions for the treatment of oral cavity and oropharyngeal cancer: with squamous cell head and neck carcinoma treated with surgery and
radiotherapy. Cochrane Database Syst Rev 2010;(12):CD006387. postperative radiotherapy. Int J Radiat Oncol Biol Phys 2007;68:119-25.
50. Pignon JP, le Maître A, Maillard E, Bourhis J; MACH-NC Collaborative 68. Expert Panel on Radiation Oncology-Head and Neck, Salama JK, Saba N,
Group. Meta-analysis of chemotherapy in head and neck cancer (MACH- Quon H, Garg MK, Lawson J, McDonald MW, Ridge JA, Smith RV, Yeung
®
NC): an update on 93 randomised trials and 17,346 patients. Radiother AR, Yom SS, Beitler JJ. ACR appropriateness criteria adjuvant therapy
Oncol 2009;92:4-14. for resected squamous cell carcinoma of the head and neck. Oral Oncol
51. Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, 2011;47:554-9.
Pignon JP; MACH-CH Collaborative group. Meta-analysis of chemotherapy 69. Bur AM, Lin A, Weinstein GS. Adjuvant radiotherapy for early head and
in head and neck cancer (MACH-NC): a comprehensive analysis by tumour neck squamous cell carcinoma with perineural invasion: a systematic
site. Radiother Oncol 2011;100:33-40. review. Head Neck 2016;38 Suppl 1:E2350-7.
52. Bourhis J, Sire C, Graff P, Grégoire V, Maingon P, Calais G, Gery B, Martin 70. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Does delay
L, Alfonsi M, Desprez P, Pignon T, Bardet E, Rives M, Geoffrois L, Daly- instarting treatment affect the outcomes of radiotherapy? a systematic
Schveitzer N, Sen S, Tuchais C, Dupuis O, Guerif S, Lapeyre M, Favrel V, review. J Clin Oncol 2003;21:555-63.
Hamoir M, Lusinchi A, Temam S, Pinna A, Tao YG, Blanchard P, Aupérin A. 71. Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship
Concomitant chemoradiotherapy versus acceleration of radiotherapy between waiting time for radiotherapy and clinical outcomes: a systematic
with or without concomitant chemotherapy in locally advanced head and review of the literature. Radiother Oncol 2008;87:3-16.
neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. 72. van Harten MC, Hoebers FJ, Kross KW, van Werkhoven ED, van den Brekel
Lancet Oncol 2012;13:145-53. MW, van Dijk BA. Determinants of treatment waiting times for head and
53. Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, neck cancer in the Netherlands and their relation to survival. Oral Oncol
Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, 2015;51:272-8.
Chung CH, Jordan RC, Gillison ML, List M, Le QT. Randomized phase III 73. Peters LJ, Withers HR. Applying radiobiological principles to combined
trial to test accelerated versus standard fractionation in combination modality treatment of head and neck cancer - the time factor. Int J
with concurrent cisplatin for head and neck carcinomas in the Radiation RadiatOncol Biol Phys 1997;39:831-6.
Therapy Oncology Group 0129 trial: long-term report of efficacy and 74. González Ferreira JA, Jaén Olasolo J, Azinovic I, Jeremic B. Effect of
toxicity. J Clin Oncol 2014;32:3858-66. radiotherapy delay in overall treatment time on local control andsurvival
54. Martinez-Useros J, Garcia-Foncillas J. The challenge of blocking a wider in head and neck cancer: review of the literature. Rep Pract Oncol Radiother
family members of EGFR against head and neck squamous cell carcinomas. 2015;20:328-39.
Oral Oncol 2015;51:423-30. 75. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, Geara
55. Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, FB, Klotch DW, Goepfert H, Peters LJ. Randomized trial addressing risk
Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK. features and time factors of surgery plus radiotherapy in advanced head-
Radiotherapy plus cetuximab for locoregionally advanced head and neck and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51:571-8.
cancer: 5-year survival data from a phase 3 randomised trial, and relation 76. Langendijk JA, de Jong MA, Leemans CR, de Bree R, Smeele LE, Doornaert
between cetuximab-induced rash and survival. Lancet Oncol 2010;11:21-8. P, Slotman BJ. Postoperative radiotherapy in squamous cell carcinoma of
56. Fletcher GH, Evers WT. Radiotherapeutic management of surgical the oral cavity: the importance of the overall treatment time. Int J Radiat
recurrences and postoperative residuals tumors of the head and neck. Oncol Biol Phys 2003;57:693-700.
Radiology 1970:95:185-8. 77. Peters LJ, Goepfert H, Ang KK, Byers RM, Maor MH, Guillamondegui O,
57. Marcus RB Jr, Million RR, Cassissi NJ. Postoperative irradiation for Morrison WH, Weber RS, Garden AS, Frankenthaler RA, Oswald MJ, Brown
squamous cell carcinomas of the head and neck: analysis of time-dose BW. Evaluation of the dose for postoperative radioation therapy of head
factors related to control above the clavicles. Int J Radiat Oncol Biol Phys and neck cancer: first report of a prospective randomized trial. Int J Radiat
1979;5:1943-49. Oncol Biol Phys 1993;26:3-11.
58. Lundahl RE, Foote RL, Bonner JA, Suman VJ, Lewis JE, Kasperbauer JL, 78. Winquist E, Oliver T, Gilbert R. Postoperative chemoradiotherapy for
McCaffrey TV, Olsen KD. Combined neck dissection and postoperative advanced squamous cell carcinoma of the head and neck: a systematic
radiation therapy in the management of the high-risk neck: a matched-pair review with meta-analysis. Head Neck 2007;29:38-46.
analysis. Int J Radiat Oncol Biol Phys 1998;40:529-34. 79. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A,
59. Lavaf A, Genden EM, Cesaretti JA, Packer S, Kao J. Adjuvant radiotherapy Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefèbvre JL. Defining risk levels
improves overall survival for patients with lymph node-positive head and in locally advanced head and neck cancers: a comparative analysis of
neck squamous cell carcinoma. Cancer 2008;112:535-43. concurrent postoperative radiation plus chemotherapy trials of EORTC
60. Kao J, Lavaf F, Teng MS, Huang D, Genden EM. Adjuvant radiotherapy and (#22931) and RTOG (#9501). Head Neck 2005;27:843-50.
survival for patients with node-positive head and neck cancer: an analysis 80. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB,
by primary site and nodal stage. Int J Radiat Oncol Biol Phys 2008;71:362-70. Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS,
61. Hu KS, Quon H, Harrison LB. Management of the neck: radiation therapy Schultz CJ, Lee N, Fu KK; Radiation Therapy Oncology Group 9501/
and chemotherapy. In: Harrison LB, Sessions RB, Hong WK, editors. Head Intergroup. PostpeRative concurrent radiotherapy and chemotherapy for
and Neck Cancer. A Multidisciplinary Approach. 3rd ed. Philadelphia: high risk squamous cell carcinoma of the head and neck. N Engl J Med
Lippincot-Williams & Wilkins; 2009. p. 204-31. 2004;350:1937-44.
62. Moergel M, Meurer P, Ingel K, Wendt TG, Al-Nawas B. Effectiveness of 81. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner
Postoperative Radiotherapy in Patients with Small Oral and Oropharyngeal RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick
Squamous Cell Carcinoma and Concomitant Ipsilateral Singular Cervical A, van Glabbeke M; European Organization for Research and Treatment of
Lymph Node Metastasis (pN1). Strahlenther Onkol 2011;187:337-43. Cancer Trial 22931. Postoperative irradiation with or without concomitant
63. Shrime MG, Gullane PJ, Dawson L, Kim J, Gilbert RW, Irish JC, Brown DH, chemotherapy for locally advanced head and neck cancer. N Engl J Med
Goldstein DP. The impact of adjuvant radiotherapy on survival in T1-2N1 2004;350:1945-52.
Plast Aesthet Res || Volume 3 || May 25, 2016 165